Attributes | Values |
---|
rdf:type
| |
Description
| - The prospective study examined the influence of folic acid (20 mg/week) on the pharmacokinetics of oral methotrexate and its therapeutic effect in patients with plaque psoriasis (PASI score) and toxicity.
- The prospective study examined the influence of folic acid (20 mg/week) on the pharmacokinetics of oral methotrexate and its therapeutic effect in patients with plaque psoriasis (PASI score) and toxicity. (en)
- Prospektivní klinická studie hodnotila vliv farmakologické suplementace kyselinou listovou na farmakokinetiku perorálního metotrexátu a jeho účinek (skóre PASI) a nežádoucí účinky u nemocných s psoriázou.ntal period - a risk group for the development of non-compliance. Similarly to other age groups, in chronic diseases the periods at risk are especially those without symptoms. The article outlines a survey of forms and factors on n (cs)
|
Title
| - The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
- The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis (en)
- Vliv suplementace kyselinou listovou na farmakokinetiku a farmakodynamiku perorálního metotrexátu ve fázi indukce remise psoriázy (cs)
|
skos:prefLabel
| - The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
- The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis (en)
- Vliv suplementace kyselinou listovou na farmakokinetiku a farmakodynamiku perorálního metotrexátu ve fázi indukce remise psoriázy (cs)
|
skos:notation
| - RIV/00216208:11150/08:00106752!RIV09-MZ0-11150___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1P05OC066), P(NR7947), Z(MSM0021620820)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11150/08:00106752
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - methotrexate; folic acid; psoriasis; psoriasis area and severity index (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - DE - Spolková republika Německo
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Clinical Pharmacology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Beránek, Martin
- Chládek, Jaroslav
- Chládková, Jiřina
- Vaněčková, Jaroslava
- Hroch, Miloš
- Vávrová, Jaroslava
- Martínková, Jiřina
- Šimková, Marie
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |